Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 11;58(11):1627.
doi: 10.3390/medicina58111627.

HYSTEROSCOPIC MYOMECTOMY

Ricardo Bassil Lasmar  1 , Bernardo Portugal Lasmar  2   3   4 , Nash S Moawad  5   6   7
Affiliations
Review

HYSTEROSCOPIC MYOMECTOMY

Ricardo Bassil Lasmar et al. Medicina (Kaunas). .

Abstract

Leiomyomas are the most common pelvic tumors. Submucosal fibroids are a common cause of abnormal bleeding and infertility. Hysteroscopic myomectomy is the definitive management of symptomatic submucosal fibroids, with high efficacy and safety. Several techniques have been introduced over time and will be covered in depth in this manuscript. Advances in optics, fluid management, electrosurgery, smaller diameter scopes, and tissue removal systems, along with improved training have contributed to improving the safety and efficiency of hysteroscopic myomectomy.

Keywords: fibroids; hysteroscopic myomectomy; leiomyomas; submucosal.

PubMed Disclaimer

Conflict of interest statement

Moawad is a consultant for Medtronic, CooperSurgical, Inc. and Myovant Sciences. No other authors have conflict of interest.

Figures

Figure 1
Figure 1
Submucous myoma—hysteroscopic view.
Figure 2
Figure 2
Submucous myoma on ultrasound. * Submucosal fibroid.
Figure 3
Figure 3
Submucous myoma in sonohysterography.
Figure 4
Figure 4
MRI with submucous myoma.
Figure 5
Figure 5
The effect of nearby fibroids.
Figure 6
Figure 6
Laparotomic and laparoscopic myomectomy preserving pseudocapsule.
Figure 7
Figure 7
Office hystreroscopic myomectomy with scissor.
Figure 8
Figure 8
Office hysteroscopic myomectomy with miniresectoscope.
Figure 9
Figure 9
Correlation with hysteroscope angulation and tissue depth.
Figure 10
Figure 10
Slicing technique.
Figure 11
Figure 11
Morcellator technique—hysteroscopic mechanical tissue removal.
Figure 12
Figure 12
LASER in submucous myoma with deep intramural component.
Figure 13
Figure 13
Mazzon technique with “cold loop”.
Figure 14
Figure 14
OR hysteroscopic myomectomy, with Collins electrode, enucleation, and preserving pseudocapsule.
See this image and copyright information in PMC

References

    1. Van Dongen H., de Kroon C.D., Jacobi C.E., Trimbos J.B., Jansen F.W. Diagnostic hysteroscopy in abnormal uterine bleeding: A systematic review and meta-analysis. BJOG. 2007;114:664–675. doi: 10.1111/j.1471-0528.2007.01326.x. - DOI - PubMed
    1. Kim J.J., Sefton E.C. The role of progesterone signaling in the pathogenesis of uterine leiomyoma. Mol. Cell. Endocrinol. 2012;358:223–231. doi: 10.1016/j.mce.2011.05.044. - DOI - PMC - PubMed
    1. Reis F.M., Bloise E., Ortiga-Carvalho T.M. Hormones and pathogenesis of uterine fibroids. Best Pract. Res. Clin. Obstet. Gynaecol. 2016;34:13–24. doi: 10.1016/j.bpobgyn.2015.11.015. - DOI - PubMed
    1. Bulun S.E., Simpson E.R., Word R.A. Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture. J. Clin. Endocrinol. Metab. 1994;78:736–743. doi: 10.1210/jcem.78.3.8126151. - DOI - PubMed
    1. Peddada S.D., Laughlin S.K., Miner K., Guyon J.-P., Haneke K., Vahdat H.L., Semelka R.C., Kowalik A., Armao D., Davis B., et al. Growth of uterine leiomyomata among premenopausal black and white women. Proc. Natl. Acad. Sci. USA. 2008;105:19887–19892. doi: 10.1073/pnas.0808188105. - DOI - PMC - PubMed